Vasopressin in Liver Disease – Should We Turn On or Off?
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
156-165
Author(s):
Robert Lo, Andrew Austin and Jan Freeman
Benefits of Exercise Training in Secondary Prevention of Coronary and Peripheral Arterial Disease
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
5
Page:
156-168
Author(s):
Surya M. Artham, Carl J. Lavie, Richard V. Milani, Yung-Wei Chi and Corey K. Goldman
Endothelial Function Assessment in Complicated Hypertension
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1761-1770
Author(s):
A. Virdis, L. Ghiadoni, D. Versari, C. Giannarelli, A. Salvetti and S. Taddei
Radionuclide PET and PET/CT in Coronary Artery Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1798-1814
Author(s):
D. Neglia, O. Rimoldi, P. A. Kaufmann and P. G. Camici
Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Journal:
Current Cardiology Reviews
Volume:
4
Page:
123-139
Author(s):
Jennifer K. Lee, R. Blaine Easley and Kenneth M. Brady
Advanced Glycation End Products and Cardiovascular Disease
Journal:
Current Diabetes Reviews
Volume:
4
Page:
92-100
Author(s):
Melpomeni Peppa and Sotirios A. Raptis
The Relationships between the Transforming Growth Factor-β 1, Age and the Ultrasound Parameters of Arterial Wall
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
5
Page:
140-144
Author(s):
Dana Skultetyova, Slavomira Filipova, Igor Riecansky and Jan Skultety
Adiponectin and its Role in Cardiovascular Diseases
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
7-46
Author(s):
Jerzy Beltowski, Anna Jamroz-Wisniewska and Sylwia Widomska
Cerebroprotective Functions of HO-2
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
443-453
Author(s):
Helena Parfenova and Charles W. Leffler
Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Journal:
Current Drug Targets
Volume:
9
Page:
14-36
Author(s):
Peter J. Oates